Sanford C. Bernstein set a €129.00 ($159.26) price objective on Bayer (FRA:BAYN) in a research note issued to investors on Wednesday morning. The firm currently has a buy rating on the healthcare company’s stock.
A number of other brokerages have also issued reports on BAYN. UBS Group set a €125.00 ($154.32) target price on shares of Bayer and gave the company a buy rating in a research note on Monday, November 6th. JPMorgan Chase & Co. restated a buy rating on shares of Bayer in a research note on Wednesday. Berenberg Bank set a €124.00 ($153.09) target price on shares of Bayer and gave the company a neutral rating in a research note on Tuesday, December 5th. Warburg Research set a €121.00 ($149.38) target price on shares of Bayer and gave the company a neutral rating in a research note on Thursday, January 11th. Finally, Jefferies Group set a €125.00 ($154.32) target price on shares of Bayer and gave the company a buy rating in a research note on Monday. One research analyst has rated the stock with a sell rating, seven have given a hold rating and fourteen have issued a buy rating to the company. Bayer has an average rating of Buy and an average price target of €121.52 ($150.03).
Shares of Bayer (FRA:BAYN) traded down €1.44 ($1.78) during trading on Wednesday, hitting €94.79 ($117.02). 1,725,091 shares of the stock were exchanged. The firm has a market cap of $78,350.00 and a price-to-earnings ratio of 25.48. Bayer has a 1-year low of €93.30 ($115.19) and a 1-year high of €123.82 ($152.86).
COPYRIGHT VIOLATION WARNING: This article was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3230364/bayer-bayn-given-a-129-00-price-target-at-sanford-c-bernstein.html.
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, Crop Science, Animal Health, and Covestro segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.
Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.